"UCR arbetar med klinisk forskning, klinisk prövning och kvalitetsutveckling. Hos oss har du direkt tillgång till alla de stödmetoder som behövs för att snabbt starta och driva projekt. UCR tar hand om många tidskrävande uppgifter, höjer kvaliteten och effektiviserar ditt och dina medarbetares arbete."

During the past decade, Uppsala Clinical Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Uppsala Clinical Research Center" are "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials), "Heart Diseases" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Uppsala Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Uppsala Clinical Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uppsala Clinical Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Uppsala Clinical Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Uppsala Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uppsala Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".